Literature DB >> 8169662

Uptake and metabolism of sphingolipids in isolated intestinal loops of mice.

E M Schmelz1, K J Crall, R Larocque, D L Dillehay, A H Merrill.   

Abstract

Sphingolipids are found in all eukaryotic organisms. However, little is known about the digestion, uptake and subsequent metabolism of these constituents of food. In this study, radiolabeled sphingolipids were placed in isolated intestinal segments of female CF1 mice, and the metabolism and distribution of the radiolabel were followed. Most of the sphingomyelin was degraded to ceramide and other products in all regions of the intestine, and increasing amounts of several [3H]-labeled sphingolipids appeared in the tissues. Small amounts of the radiolabel disappeared from the intestinal loops and appeared in liver within the first 30 to 60 min implying that neither intact sphingomyelin nor its metabolites are transported very efficiently from the intestine to other organs. There were different degrees of uptake and metabolism of sphingomyelin, [4,5-3H-sphinganyl]ceramide, and [3H]sphingosine. The [3H]sphingomyelin was also administered by gavage and the appearance along the intestine measured. After 90 min, 12% was found in the cecum and colon. These results establish that some of the sphingomyelin that enters the gastrointestinal tract is hydrolyzed and taken up by the intestine, with the lipid backbone being degraded or reutilized for complex sphingolipid synthesis; however, at least a portion passes into the large intestine. The appearance of bioactive compounds throughout the gastrointestinal tract may alter the behavior of intestinal cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8169662     DOI: 10.1093/jn/124.5.702

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  40 in total

1.  Bactericidal activities of milk lipids.

Authors:  R C Sprong; M F Hulstein; R Van der Meer
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

2.  Single-dose FTY720 pharmacokinetics, food effect, and pharmacological responses in healthy subjects.

Authors:  John M Kovarik; Robert Schmouder; Denise Barilla; Yibin Wang; Gerolf Kraus
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

Review 3.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

Review 4.  An update on the biology of sphingosine 1-phosphate receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  J Lipid Res       Date:  2014-01-23       Impact factor: 5.922

5.  Sphingoid bases of dietary ceramide 2-aminoethylphosphonate, a marine sphingolipid, absorb into lymph in rats.

Authors:  Nami Tomonaga; Tsuyoshi Tsuduki; Yuki Manabe; Tatsuya Sugawara
Journal:  J Lipid Res       Date:  2018-12-14       Impact factor: 5.922

6.  Intestinal absorption of dietary maize glucosylceramide in lymphatic duct cannulated rats.

Authors:  Tatsuya Sugawara; Tsuyoshi Tsuduki; Saeko Yano; Mayumi Hirose; Jingjing Duan; Kazuhiko Aida; Ikuo Ikeda; Takashi Hirata
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

7.  Digestion of Ceramide 2-Aminoethylphosphonate, a Sphingolipid from the Jumbo Flying Squid Dosidicus gigas, in Mice.

Authors:  Nami Tomonaga; Yuki Manabe; Tatsuya Sugawara
Journal:  Lipids       Date:  2017-02-27       Impact factor: 1.880

8.  Dietary glucosylceramide enhances cornified envelope formation via transglutaminase expression and involucrin production.

Authors:  Tatsuya Hasegawa; Haruo Shimada; Taro Uchiyama; Osamu Ueda; Masaya Nakashima; Yasuhiro Matsuoka
Journal:  Lipids       Date:  2011-03-17       Impact factor: 1.880

9.  Sphingosine 1-phosphate receptor signaling regulates proper embryonic vascular patterning.

Authors:  Karen Mendelson; Tomasz Zygmunt; Jesús Torres-Vázquez; Todd Evans; Timothy Hla
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

Review 10.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.

Authors:  William L Holland; Scott A Summers
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.